News|Videos|December 4, 2024

Transforming “what if” to “what is” with the Veradigm Network

Our network connects providers, health plans, and life science companies to deliver seamless care that benefits everyone

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.

The Transition to Home: Why Confidence is Critical to Patient Success

ByJoe Reynolds, Noble

September 9th 2026

Sponsored

Logan Melchione, Paysign, talks ClaimGuardRx

ClaimGuardRx Gives Account Teams Instant Answers on Diversion and Fraud

ByLogan Melchione, Paysign

September 9th 2026

Sponsored

Bryan Dennison, Paysign, talks ClaimGuardRx

How ClaimGuardRx's Purpose-Built AI Detects and Counters Diversion Tactics

ByBryan Dennison, Paysign

September 9th 2026

Sponsored

Matt Turner, Paysign, talks ClaimGuardRx

ClaimGuardRx Supports Patient Affordability From the Start

ByMatt Turner, Paysign

September 9th 2026

Sponsored

Launch is Just the Beginning: Rare Disease Care Requires Durability

ByBansi Nagji, CEO, PANTHERx Rare

July 7th 2026

Sponsored

Trending on PharmExec

Artisan Partners’ Director Calls for Novartis Board Shake-Up

The Agentic AI Revolution in Biopharma

340B Under Pressure: Inside Pharma's Push for Greater Clarity

Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes

Pharmaceutical Executive Daily: David Samra Calls For Novartis Board Shake-Up